Key result
NCEP guidelines recommend cholesterol screening for all Americans aged 20 and older.
Answers are grounded in this paper and cite their sources.
Deciding who should be screened and treated for elevated cholesterol levels has profound implications for the health of our nation. Depending on the selection criterion for screening, the costs of screening and treatment and the potential savings by preventing myocardial infarction and death from coronary heart disease (CHD) can be staggering. The two extreme positions regarding the appropriate population to be screened and treated are those of the National Cholesterol Education Program (NCEP)¹and of Hulley and his associates.²The NCEP recommends that all Americans aged 20 years and older be screened for high cholesterol and has prepared dietary and drug therapy guidelines for patients, millions of whom do not have clinical evidence of CHD. Since CHD is a progressive disease that may take decades to become manifest, the NCEP recommends primary as well as secondary prevention. See also p 55. Hulley and coworkers have reported that screening
No takes yet. Share an insight, caveat, or question.
James E. Dalen (1996) conducted an editorial in Elevated cholesterol / Coronary heart disease. Cholesterol screening and lowering therapy was evaluated. Cholesterol screening and treatment guidelines from the NCEP recommend screening all Americans aged ≥20 years for primary and secondary prevention of coronary heart disease.
Synapse has enriched 10 related papers. Consider them for comparative context: